Related Experiment Video
Updated: Jun 4, 2026

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis
Vincent Ho1, Lawrence Y Ho, Tushar M Ranchod
1The Ohio State University College of Medicine, Columbus, Ohio, USA.
This study reports on endogenous methicillin-resistant Staphylococcus aureus endophthalmitis, finding retinal detachments common but enucleation rates low. Outcomes show visual acuity improvement in most affected eyes.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Microbiology
Background:
- Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis is a severe intraocular infection.
- Limited data exists on the presentation, treatment, and outcomes of this condition.
Observation:
- A retrospective review of eight eyes from seven patients with culture-proven methicillin-resistant Staphylococcus aureus endophthalmitis.
- The mean age was 58.1 years, with a male predominance (5/7 patients).
- Retinal detachment occurred in six of eight eyes during treatment.
Findings:
- Initial treatment involved vitreous tap and antibiotic injection in five eyes.
- Final visual acuity varied, with 5/8 eyes showing improvement.
- Only one eye required enucleation due to blindness and pain.
Implications:
- This series, the largest single-institution report, suggests better outcomes than previously documented.
- Retinal detachment is a frequent complication, but aggressive management may lead to favorable visual results.
- Findings challenge prior assumptions of universally poor outcomes and high enucleation rates for this infection.
Related Concept Videos
Staphylococcal Skin Infections
Endocarditis I: Introduction
Clinical Significance of Antibiotic Resistance
Microbiome of the Eye
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
